Cardiac sympathetic activation circumvents high-dose beta blocker therapy in part through release of neuropeptide YJonathan D. Hoang(University of California, Los Angeles), Marmar Vaseghi(University of California, Los Angeles)JCI InsightJune 4, 202010.1172/jci.insight.135519Cited by 47SaveCiteExport RISWatch citationsRelated PapersFreedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study|Heart Rhythm|2015|497European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population|EP Europace|2020|93Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC—endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm Society|EP Europace|2024|76Tyrosine Hydroxylase-Expressing Neurons in the Vagal Ganglia: Characterization and Implications|Biomedicines|2025|0